JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong · Delayed Price · Currency is HKD 2.260
-0.050 (-2.16%)
Feb 13, 2026, 4:08 PM HKT
HKG:2126 Market Cap
HKG:2126 has a market cap or net worth of 916.74 million as of February 13, 2026. Its market cap has increased by 72.92% in one year.
Market Cap
916.74M
Enterprise Value
615.87M
Revenue
194.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.26
Market Cap Chart
Since November 3, 2020, HKG:2126's market cap has decreased from 8.28B to 916.74M, a decrease of -88.92%. That is a compound annual growth rate of -34.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 937.03M | -7.97% |
| Dec 31, 2025 | 1.02B | 96.55% |
| Dec 31, 2024 | 518.01M | -42.89% |
| Dec 29, 2023 | 907.01M | -47.90% |
| Dec 30, 2022 | 1.74B | -67.36% |
| Dec 31, 2021 | 5.33B | -47.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.43B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.35B |
| Shanghai Bio-heart Biological Technology | 1.31B |
| Brii Biosciences | 1.13B |
| Transcenta Holding | 1.08B |
| 3D Medicines | 1.00B |